SRRK
Price
$30.70
Change
-$1.84 (-5.65%)
Updated
Apr 3 closing price
Capitalization
2.91B
34 days until earnings call
VERU
Price
$0.58
Change
-$0.05 (-7.94%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
85.09M
33 days until earnings call
Ad is loading...

SRRK vs VERU

Header iconSRRK vs VERU Comparison
Open Charts SRRK vs VERUBanner chart's image
Scholar Rock Holding
Price$30.70
Change-$1.84 (-5.65%)
Volume$995.59K
Capitalization2.91B
Veru
Price$0.58
Change-$0.05 (-7.94%)
Volume$36.68K
Capitalization85.09M
SRRK vs VERU Comparison Chart
Loading...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SRRK vs. VERU commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRRK is a Hold and VERU is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (SRRK: $30.70 vs. VERU: $0.58)
Brand notoriety: SRRK and VERU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SRRK: 100% vs. VERU: 65%
Market capitalization -- SRRK: $2.91B vs. VERU: $85.09M
SRRK [@Biotechnology] is valued at $2.91B. VERU’s [@Biotechnology] market capitalization is $85.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRRK’s FA Score shows that 0 FA rating(s) are green whileVERU’s FA Score has 0 green FA rating(s).

  • SRRK’s FA Score: 0 green, 5 red.
  • VERU’s FA Score: 0 green, 5 red.
According to our system of comparison, SRRK is a better buy in the long-term than VERU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRRK’s TA Score shows that 4 TA indicator(s) are bullish while VERU’s TA Score has 4 bullish TA indicator(s).

  • SRRK’s TA Score: 4 bullish, 4 bearish.
  • VERU’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both SRRK and VERU are a good buy in the short-term.

Price Growth

SRRK (@Biotechnology) experienced а -7.97% price change this week, while VERU (@Biotechnology) price change was +6.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

SRRK is expected to report earnings on May 08, 2025.

VERU is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($2.91B) has a higher market cap than VERU($85.1M). VERU YTD gains are higher at: -10.638 vs. SRRK (-28.968). VERU has higher annual earnings (EBITDA): -38.84M vs. SRRK (-250.12M). SRRK has more cash in the bank: 437M vs. VERU (26.6M). VERU has less debt than SRRK: VERU (3.52M) vs SRRK (65.1M). VERU has higher revenues than SRRK: VERU (16.9M) vs SRRK (0).
SRRKVERUSRRK / VERU
Capitalization2.91B85.1M3,416%
EBITDA-250.12M-38.84M644%
Gain YTD-28.968-10.638272%
P/E RatioN/AN/A-
Revenue016.9M-
Total Cash437M26.6M1,643%
Total Debt65.1M3.52M1,850%
FUNDAMENTALS RATINGS
SRRK vs VERU: Fundamental Ratings
SRRK
VERU
OUTLOOK RATING
1..100
5522
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3547
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRRK's Valuation (66) in the Biotechnology industry is somewhat better than the same rating for VERU (100) in the Household Or Personal Care industry. This means that SRRK’s stock grew somewhat faster than VERU’s over the last 12 months.

SRRK's Profit vs Risk Rating (74) in the Biotechnology industry is in the same range as VERU (100) in the Household Or Personal Care industry. This means that SRRK’s stock grew similarly to VERU’s over the last 12 months.

SRRK's SMR Rating (98) in the Biotechnology industry is in the same range as VERU (98) in the Household Or Personal Care industry. This means that SRRK’s stock grew similarly to VERU’s over the last 12 months.

SRRK's Price Growth Rating (35) in the Biotechnology industry is in the same range as VERU (47) in the Household Or Personal Care industry. This means that SRRK’s stock grew similarly to VERU’s over the last 12 months.

SRRK's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VERU (100) in the Household Or Personal Care industry. This means that SRRK’s stock grew similarly to VERU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRRKVERU
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 18 days ago
85%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCTCX40.40N/A
N/A
Goldman Sachs US Tax-Managed Eq C
EMRYX13.93N/A
N/A
VanEck Emerging Markets Y
OAZGX34.14N/A
N/A
Oakmark Global R6
PHLOX9.78N/A
N/A
Philotimo Focused Growth and Income
RIDHX24.95-0.52
-2.04%
American Funds Income Fund of Amer R5E

VERU and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERU has been loosely correlated with ALLK. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VERU jumps, then ALLK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERU
1D Price
Change %
VERU100%
-8.43%
ALLK - VERU
47%
Loosely correlated
-0.37%
PXXLF - VERU
37%
Loosely correlated
N/A
PRAX - VERU
35%
Loosely correlated
-10.08%
QLGN - VERU
34%
Loosely correlated
-2.93%
SRRK - VERU
32%
Poorly correlated
-5.65%
More